Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202111481740832Phase 4Not yet recruiting
Phase 4, randomised trial in community-acquired pneumonia (CAP) (2 arms), sponsored by University of Oxford. Primary endpoint: Mortality at 30 days after randomization. Planned start Nov 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202111481740832.